Does GEMFIBROZIL Cause Myopathy? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Myopathy have been filed in association with GEMFIBROZIL (Gemfibrozil). This represents 0.7% of all adverse event reports for GEMFIBROZIL.
8
Reports of Myopathy with GEMFIBROZIL
0.7%
of all GEMFIBROZIL reports
0
Deaths
5
Hospitalizations
How Dangerous Is Myopathy From GEMFIBROZIL?
Of the 8 reports, 5 (62.5%) required hospitalization.
Is Myopathy Listed in the Official Label?
Yes, Myopathy is listed as a known adverse reaction in the official FDA drug label for GEMFIBROZIL.
What Other Side Effects Does GEMFIBROZIL Cause?
Drug hypersensitivity (242)
Drug ineffective (77)
Rhabdomyolysis (63)
Fatigue (60)
Drug interaction (59)
Myalgia (58)
Nausea (54)
Acute kidney injury (52)
Diarrhoea (43)
Rash (41)
What Other Drugs Cause Myopathy?
ATORVASTATIN (1,243)
SIMVASTATIN (624)
ROSUVASTATIN (596)
PREDNISONE (526)
METHYLPREDNISOLONE (321)
PREDNISOLONE (246)
DEXAMETHASONE (203)
METFORMIN (197)
METHOTREXATE (196)
MYCOPHENOLATE MOFETIL (177)
Which GEMFIBROZIL Alternatives Have Lower Myopathy Risk?
GEMFIBROZIL vs GEMTUZUMAB OZOGAMICIN
GEMFIBROZIL vs GEMZAR
GEMFIBROZIL vs GENTAMICIN
GEMFIBROZIL vs GEODON
GEMFIBROZIL vs GILENYA